Edition:
United States

Avid Bioservices Inc (CDMO.OQ)

CDMO.OQ on NASDAQ Stock Exchange Capital Market

3.54USD
1:26pm EDT
Change (% chg)

$0.27 (+8.26%)
Prev Close
$3.27
Open
$3.32
Day's High
$3.59
Day's Low
$3.30
Volume
66,236
Avg. Vol
95,590
52-wk High
$5.77
52-wk Low
$2.25

Chart for

About

Avid Bioservices, Inc., formerly Peregrine Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is engaged in providing contract manufacturing services for third party customers on a fee-for-service basis while also supporting its internal drug development efforts. The Company delivers pharmaceutical products... (more)

Overall

Beta: 2.04
Market Cap(Mil.): $185.54
Shares Outstanding(Mil.): 55.55
Dividend: --
Yield (%): --

Financials

  CDMO.OQ Industry Sector
P/E (TTM): -- 28.95 33.54
EPS (TTM): -0.55 -- --
ROI: -52.59 13.56 13.09
ROE: -69.19 15.37 15.10

BRIEF-Avid Bioservices Provides Update On Ongoing Expansion Of Process Development Capabilities And Laboratory Infrastructure

* AVID BIOSERVICES PROVIDES UPDATE ON ONGOING EXPANSION OF PROCESS DEVELOPMENT CAPABILITIES AND LABORATORY INFRASTRUCTURE

Apr 24 2018

BRIEF-Avid Bioservices Selected By Acumen Pharmaceuticals To Lead Process Development And Clinical Manufacture Of Novel Alzheimer's Disease Candidate

* AVID BIOSERVICES SELECTED BY ACUMEN PHARMACEUTICALS TO LEAD PROCESS DEVELOPMENT AND CLINICAL MANUFACTURE OF NOVEL ALZHEIMER’S DISEASE CANDIDATE

Mar 01 2018

BRIEF-Avid Bioservices Announces Proposed Offering Of Common Stock

* AVID BIOSERVICES ANNOUNCES PROPOSED OFFERING OF COMMON STOCK

Feb 14 2018

BRIEF-Avid Bioservices, Oncologie Enter Into Asset Assignment, Purchase Agreement For Avid's PS-Targeting Program Including Bavituximab

* AVID BIOSERVICES AND ONCOLOGIE ENTER INTO ASSET ASSIGNMENT AND PURCHASE AGREEMENT FOR AVID’S PS-TARGETING PROGRAM INCLUDING BAVITUXIMAB

Feb 12 2018

Competitors

  Price Chg
DAIICHI SANKYO COMPANY, LIMITED (4568.T) ¥4,315 -36.00
HANALL BIOPHARMA (009420.KS) ₩27,100.00 +600.00
Pfizer Inc. (PFE.N) $36.51 +0.22
Johnson & Johnson (JNJ.N) $123.12 +1.67
Novartis AG (NOVN.S) CHF75.60 +0.10
Merck & Co., Inc. (MRK.N) $61.71 +0.53
Roche Holding Ltd. (ROG.S) CHF216.45 --
Roche Holding Ltd. (RO.S) CHF223.60 +4.00
Bayer AG (BAYGn.DE) €98.84 +2.45
Bayer AG (BAYE.F) -- --

Earnings vs. Estimates